Publication | Closed Access

Fatty acid oxidation enzyme Δ3, Δ2-enoyl-CoA isomerase 1 (ECI1) drives aggressive tumor phenotype and predicts poor clinical outcome in prostate cancer patients

OncologyBiochemistryAggressive Tumor PhenotypeMedicineProstate Cancer Patientsδ2-Enoyl-coa Isomerase 1Prostatic DiseaseSystems BiologyCancer MetabolismRadiation OncologyTumor BiologyEndocrine-related Cancer